Heartflow (NASDAQ:HTFL) Director Julie Cullivan Sells 8,000 Shares

Heartflow, Inc. (NASDAQ:HTFL) Director Julie Cullivan sold 8,000 shares of the firm’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $27.32, for a total transaction of $218,560.00. Following the completion of the transaction, the director directly owned 36,413 shares of the company’s stock, valued at $994,803.16. This represents a 18.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Heartflow Price Performance

NASDAQ HTFL opened at $29.29 on Tuesday. The stock’s fifty day moving average price is $30.31. Heartflow, Inc. has a 1 year low of $25.38 and a 1 year high of $41.22. The company has a market capitalization of $2.49 billion and a price-to-earnings ratio of -16.18.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HTFL shares. Weiss Ratings reissued a “sell (d)” rating on shares of Heartflow in a research report on Monday, December 29th. Stifel Nicolaus lifted their target price on Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. JPMorgan Chase & Co. increased their price target on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research note on Thursday, November 13th. Canaccord Genuity Group raised their price target on Heartflow from $39.00 to $40.00 and gave the company a “buy” rating in a report on Thursday, November 13th. Finally, Wells Fargo & Company began coverage on shares of Heartflow in a report on Wednesday, January 28th. They issued an “overweight” rating and a $38.00 price objective on the stock. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $38.50.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. TFC Financial Management Inc. bought a new position in Heartflow during the 3rd quarter worth $40,000. Legal & General Group Plc bought a new position in Heartflow during the third quarter worth about $59,000. Strs Ohio acquired a new stake in Heartflow in the 4th quarter worth about $99,000. Staley Capital Advisers Inc. bought a new stake in Heartflow in the 4th quarter valued at about $204,000. Finally, Connable Office Inc. acquired a new stake in shares of Heartflow in the fourth quarter valued at approximately $220,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.